PDSB

NASD PDS Biotechnology Corp.
Oct 1, 2026 · 4:26 PM ET LAST TRADE Market Closed

$0.7224 ↑ +0.0163 (+2.31%) Trading Up from the previous close of $0.7061, $0.0376 below the day’s high of $0.7600

YTD change
-6.16%
vs 20-day SMA
+21.31%
vs 200-day SMA
-9.37%

Price ranges

Previous day
$0.7101 $0.7606
open $0.7180 close $0.7507
+$0.0327 (+4.55%)
Today
$0.7003 $0.7600
open $0.7499 now $0.7224
-$0.0275 (-3.67%)
Past week
$0.7101 $0.8239
from $0.8239 now $0.7224
-$0.1015 (-12.32%)
Past month
$0.2010 $1.0600
from $0.2040 now $0.7224
+$0.5184 (+254.12%)
This year
$0.1952 $1.5500
from $0.7698 now $0.7224
-$0.0474 (-6.16%)

Price & Performance

+0.14 (+23.82%) / 6M

$0.1024$0.5777$1.05$1.53Apr 1Jul 1Sep 30

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 96.0% away from all-time highs of $17.8500
  • PDSB is down 6% since the beginning of the year
  • PDSB is down 29% over the past 12 months
  • PDSB is up 254% over the past 1 month
  • 12% of all PDSB investors are betting against PDSB

PDSB reads not so good: price sits above one of the two key moving averages, the 12-month move is -26.4%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.18
Earnings momentum -63.6% Quarterly EPS growth
Quarterly change -63.6%

Valuation

P/E ratio N/A
Enterprise value $40.6M
Beta 2.40

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$5.6M
Debt$4.4K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $70.0M

PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products include PDS0101 and PDS01ADC. The company was founded by Frank K. Bedu-Addo in 2005 and is headquartered in Princeton, NJ.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $421.51 -0.50%
MRNA Moderna, Inc. $192.57 -5.35%
RVMD Revolution Medicines, Inc. $205.26 +0.38%
ROIV Roivant Sciences Ltd. $36.57 +0.19%
BNTX BioNTech SE Sponsored ADR $98.30 -0.27%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.